SKOV3 and IGROV1 cells grown as monolayers and spheroids were transiently co-transfected with plasmids at a 10:1 ratio using DreamFect Gold transfection reagent. siRNA were efficiently delivered into SKOV3 with DreamFect.
This article demonstrates the high efficiency of DreamFect Gold from OZ Biosciences for DNA transfection into ovarian cancer cell lines and the capacity of DreamFect to silence gene expression in SKOV3.article reference: Oncogene. 2014 Jun 23. doi: 10.1038/onc.2014.178.
β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids.
Abstract
Cancer cells form
three-dimensional (3D) multicellular aggregates (or spheroids) under
non-adherent culture conditions. In ovarian cancer (OC), spheroids serve
as a vehicle for cancer cell dissemination in the peritoneal cavity,
protecting cells from environmental stress-induced anoikis. To identify
new targetable molecules in OC spheroids, we investigated gene
expression profiles and networks upregulated in 3D vs traditional
monolayer culture conditions. We identified ALDH1A1, a cancer stem cell
marker as being overexpressed in OC spheroids and directly connected to
key elements of the β-catenin pathway. β-Catenin function and ALDH1A1
expression were increased in OC spheroids vs monolayers and in
successive spheroid generations, suggesting that 3D aggregates are
enriched in cells with stem cell characteristics. β-Catenin knockdown
decreased ALDH1A1 expression levels and β-catenin co-immunoprecipitated
with the ALDH1A1 promoter, suggesting that ALDH1A1 is a direct β-catenin
target. Both short interfering RNA-mediated β-catenin knockdown and A37
((ethyl-2-((4-oxo-3-(3-(pryrrolidin-1-yl)propyl)-3,4-dihydrobenzo
[4,5]thioeno [3,2-d]pyrimidin-2-yl)thio)acetate)), a novel ALDH1A1
small-molecule enzymatic inhibitor described here for the first time,
disrupted OC spheroid formation and cell viability (P<0.001).
β-Catenin knockdown blocked tumor growth and peritoneal metastasis in an
OC xenograft model. These data strongly support the role of
β-catenin-regulated ALDH1A1 in the maintenance of OC spheroids and
propose new ALDH1A1 inhibitors targeting this cell population.Oncogene
advance online publication, 23 June 2014; doi:10.1038/onc.2014.178.
No comments:
Post a Comment